English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduResearchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety.
Tag: LSD
Reduced frequency & intensity of migraine attacks after single dose of psilocybin
Psilocybin – the active ingredient in psychedelic mushrooms – shows promise for the transitional treatment of episodic migraines in early clinical trials, according to a review from Yale School of Medicine’s Emmanuelle Schindler, M.D., Ph.D. In the first and only…
Predicting who may do best with psychedelic-assisted therapy
A new research review identifies personality traits that have been associated with positive and negative experiences on psychedelics being tested for therapeutic purposes in previous studies, information that could help predict how future clinical trial participants will respond to the drugs.
One psychedelic experience may lessen trauma of racial injustice
A single positive experience on a psychedelic drug may help reduce stress, depression and anxiety symptoms in Black, Indigenous and people of color whose encounters with racism have had lasting harm, a new study suggests.